Revance Therapeutics, Inc. [RVNC]

Source: 

Company Overview

Revance Therapeutics, Inc. is a biotechnology company focused on developing and commercializing innovative aesthetic and therapeutic offerings. Revance’s portfolio includes DAXXIFY for injection and the RHA Collection of dermal fillers in the U.S. Revance has also partnered with Viatris to develop a biosimilar to onabotulinumtoxinA for injection and Fosun to commercialize DAXXIFY in China.